Pictet Asset Management (UK)’s Adaptive Biotechnologies ADPT Stock Holding History

Pictet Asset Management (UK)’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$21.5M	Buy	526,044 +104,131	+25%	+$4.05M	0.02%	503
2021 Q1	$17M	Buy	421,913 +43,501	+11%	+$2.35M	0.02%	541
2020 Q4	$22.4M	Sell	378,412 -71,229	-16%	-$3.67M	0.03%	455
2020 Q3	$21.9M	Sell	449,641 -21,043	-4%	-$884K	0.03%	415
2020 Q2	$22.8M	Sell	470,684 -54,720	-10%	-$2M	0.04%	381
2020 Q1	$14.6M	Buy	525,404 +7,185	+1%	+$200K	0.03%	422
2019 Q4	$15.5M	Buy	518,219 +90,604	+21%	+$2.6M	0.03%	489
2019 Q3	$13.2M	Buy	427,615 +52,615	+14%	+$2.15M	0.03%	475
2019 Q2	$18.1M	Buy	+375,000	New	+$16.6M	0.04%	410

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pictet Asset Management (UK)'s ADPT Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Adaptive Biotechnologies (ADPT) stake by 25% in Q2 2021, buying an estimated $4.05M and bringing the position to 526,044 shares worth $21.5M. The position accounts for 0.02% of the portfolio, ranked #503.

Pictet Asset Management (UK) first reported a position in ADPT in Q2 2019 and has held it in 9 quarters since. The position peaked at $22.8M in Q2 2020. 230 funds tracked by Wall St. Rank hold ADPT as of Q2 2021.

Pictet Asset Management (UK) held 526,044 shares of Adaptive Biotechnologies worth $21.5M as of Q2 2021.
Pictet Asset Management (UK) bought 104,131 Adaptive Biotechnologies shares in Q2 2021, an estimated $4.05M.
Adaptive Biotechnologies made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #503 holding.
Pictet Asset Management (UK) first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 9 quarters since.
Pictet Asset Management (UK)'s Adaptive Biotechnologies position peaked at $22.8M in Q2 2020.
230 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.